Trial Profile
Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome endocrinopathy (ROSE Trial)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis; Sjogren's syndrome
- Focus Therapeutic Use
- Acronyms ROSE
- 30 Jun 2011 New trial record